Bacterial, Fungal Profiles Predict Infliximab Response, Study Reveals

Bacterial, Fungal Profiles Predict Infliximab Response, Study Reveals

284881

Bacterial, Fungal Profiles Predict Infliximab Response, Study Reveals

Bacterial and fungal profiles found in fecal samples from people with inflammatory bowel disease (IBD) were able to predict the patients’ responses to the anti-inflammatory therapy infliximab, a study revealed. These findings support the development of a predictive test that would help clinicians to choose the most effective treatment for their IBD patients. The study, “Bacterial and Fungal Profiles as Markers of Infliximab Drug Response in Inflammatory Bowel Disease,” was published in the Journal of…

You must be logged in to read/download the full post.